Biomemory Launches DNA Shield for Sovereign Data Protection

The launch of DNA Shield marks a transition for the Paris and Boston-based firm, which spent the last year consolidating its market position. Following the acquisition of Catalog Technologies in March 2026 and the appointment of CEO Laurent Guengant in July, the company has pivoted toward deploying molecular IT as a tangible service. DNA Shield functions as an offline, managed layer for data that must remain tamper-evident and recoverable for decades, regardless of infrastructure shifts or cyber threats.

Under the new service, clients undergo a secure onboarding process where sensitive materials—such as cryptographic keys, proprietary industrial intellectual property, and regulated records—are encrypted and encoded into synthetic DNA. This data remains stored offline, removed from typical network-reachable attack surfaces. Recovery is managed through a controlled, deliberate process rather than routine access, ensuring that institutional memory persists independently of the software or vendor ecosystems that originally created it. According to Guengant, the platform represents the first step in a broader roadmap that includes future molecular search and computing capabilities.